** Shares of the semiconductor chip maker AXE.AX rise as
much as 11% to A$1.36, on track for their biggest single-day pct
gain since Oct. 14
** Co says it has successfully developed its first
biochemical reactions for the detection of nucleic acid
sequences for potential application at room-temprature
urn:newsml:reuters.com:*:nASX3lV6kQ
** AXE says viral, bacterial, or other microbial-origin
nucleic acid sequences would allow for the development of co's
'lab-on-a-chip' technology towards pathogen detection
** Adds that progress in developing co's bio-chip technology
could eliminate cold-logistics supply chain requirements and the
need for polymerase chain reaction testing
** Shares hit their highest since Nov. 25
** More than 2.2 mln shares change hands, compared with the
30-day average volume of ~1.1 mln shares
** Stock up 135.6% this year, as of last close
(Reporting by Roushni Nair in Bangalore.)
((Roushni.Nair@thomsonreuters.com))